• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

DNA test CEO Wojcicki talks about her “big challenge”

By
Patricia Sellers
Patricia Sellers
Down Arrow Button Icon
By
Patricia Sellers
Patricia Sellers
Down Arrow Button Icon
December 4, 2013, 1:31 PM ET
Susan and Anne Wojcicki

FORTUNE — For the first time since the FDA came down hard on 23andMe for marketing its DNA tests without proper approvals, founder and CEO Anne Wojcicki spoke about “the big challenge,” as she called the firestorm, in an exclusive interview with Fortune.

I talked with Anne and her older sister Susan Wojcicki, Google’s SVP of Ads and Commerce, on stage Tuesday evening at a
Fortune
Most Powerful Women event in San Francisco.

“We failed to communicate proactively,” Anne Wojcicki told the Fortune audience of 100 women leaders. Now scrambling to comply with the FDA’s demands, Wojcicki has stopped advertising 23andMe’s $99 DNA test kits. Meanwhile, she’s facing a class-action lawsuit that claims that her company’s ads are misleading and the results of its genetic tests aren’t supported by scientific evidence.

23andMe has plenty of financial backing to weather this storm: $126 million in funding from Google, Johnson & Johnson and Russian billionaire Yuri Milner, among others. Nonetheless, this is a seriously tough period for one of Silicon Valley’s rising star entrepreneurs. Earlier this year, Wojcicki separated from her husband, Google co-founder Sergey Brin. The couple has two children.

Elder sister Susan and their mother, Esther, who was in the audience Tuesday evening, are offering helpful advice. To solve any problems, Esther told her daughters, you need to break them down: “Big challenges are an accumulation of small challenges,” Anne said she learned from her mother.

Susan Wojcicki sympathetically noted that the genetics industry is a lot like the Internet was 15 years ago—a Wild West where the rules are newly forming and pioneers are constantly scrutinized. “In some ways, both companies [Google and 23andMe] are doing things that have never been done before,” Susan said.

For more on 23andMe’s FDA challenge and my exclusive interview with the Wojcicki sisters, read my colleague Michal Lev-ram’s post here.

About the Author
By Patricia Sellers
See full bioRight Arrow Button Icon
0

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Most Popular

placeholder alt text
Economy
‘Sell America’: Investors dump U.S. assets in fear of the end of Fed independence
By Jim EdwardsJanuary 12, 2026
13 hours ago
placeholder alt text
AI
This CEO laid off nearly 80% of his staff because they refused to adopt AI fast enough. 2 years later, he says he'd do it again
By Nick LichtenbergJanuary 11, 2026
1 day ago
placeholder alt text
Economy
A Supreme Court ruling that strikes down Trump's tariffs would be the fastest way to revive the stalling job market, top economist says
By Jason MaJanuary 11, 2026
1 day ago
placeholder alt text
Economy
Trump may be raising your taxes with his tariffs but he could actually cut inflation with them, too, SF Fed says
By Jake AngeloJanuary 6, 2026
6 days ago
placeholder alt text
Success
An exec at $62 billion giant Colgate says Gen Z workers, despite getting flak for being woke and lazy, are actually ‘pushing us to get better’
By Emma BurleighJanuary 10, 2026
3 days ago
placeholder alt text
Economy
Treasury spent $276 billion in interest on the national debt in the final three months of 2025, says the CBO—up $30 billion from a year prior
By Eleanor PringleJanuary 12, 2026
12 hours ago

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.